Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-30 Sale |
2022-12-02 5:48 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
23,131 | $46.94 | $1,085,739 | 284,364 (Indirect Direct) |
View |
| 2022-10-28 Sale |
2022-11-01 5:38 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
44,103 | $40.31 | $1,777,829 | 307,495 (Indirect Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 9:50 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
285,487 | $42.71 | $12,193,196 | 351,598 (Indirect Direct) |
View |
| 2020-11-24 Purchase |
2020-11-25 5:03 pm |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner |
375,000 | $39 | $14,625,000 | 17,161,713 (Indirect) |
View |
| 2020-07-10 Purchase |
2020-07-14 4:45 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director 10% Owner |
415,000 | $36 | $14,940,000 | 5,830,203 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-08 Option Award |
2024-06-11 5:22 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:32 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director |
7,639 | $0 | 7,639 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:48 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:23 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director |
19,441 | $0 | 19,441 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 5:00 pm |
N/A 2032-06-06 |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:25 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-25 4:57 pm |
N/A 2031-06-07 |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner |
11,650 | $0 | 11,650 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:56 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 5:26 pm |
N/A 2030-06-02 |
Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner |
14,777 | $0 | 14,777 (Direct) |
View |
| 2020-06-01 Option Award |
2020-06-02 6:52 pm |
N/A 2030-05-31 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director 10% Owner |
13,000 | $0 | 13,000 (Direct) |
View |